Purchase Order 36C25926P0013

Award Date 10/1/25
Potential Completion Date 6/30/26
Potential Value $272K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Oklahoma City, OK 73104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Veterans Integrated Service Network 19, a division of the U.S. Department of Veterans Affairs, to the University of Oklahoma Health Sciences Center. The contract is for the delivery of radiopharmaceuticals and has a ceiling value of $423,949.82. It is a firm fixed price delivery order contract with a period of performance through September 30, 2025. The University of Oklahoma Health Sciences Center is the prime contractor, and no set-aside designation is...
This is a firm fixed price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to the University of Oklahoma Health Sciences Center Division, a division of the University of Oklahoma. The contract is for the provision of radiopharmaceuticals and ancillary supplies, with a ceiling value of $416,048.90 and a period of performance ending on September 30, 2017. This contract does not have a set-aside designation. As a prime contractor, the...
This is a Delivery Order contract awarded to the University of Oklahoma (OU) by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 19 (VISN 19) for the provision of radiopharmaceuticals. The contract has a ceiling value of $476,773.61 and a performance period ending on December 6, 2024. This award is not a set-aside contract. As a prime contractor, OU has a long history of providing a range of medical goods and services, including...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 19 to the University of Oklahoma (OU) for radiopharmaceuticals. The potential value of the contract is $252,842.61 and the period of performance ends on September 30, 2020. OU, through its University of Oklahoma Health Sciences Center division, is providing radiopharmaceutical products, physician services, animal housing, and...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 19 to the University of Oklahoma (OU) for the provision of radiopharmaceuticals. The contract has a period of performance from October 1, 2018 to September 30, 2019, with a potential value of $278,285.44. OU, through its University of Oklahoma Health Sciences Center division, is the prime contractor and will deliver routine...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a firm fixed price delivery order contract to the University of Oklahoma Health Sciences Center Division for the provision of radiopharmaceuticals. The contract, which has a potential value of $278,494.90, has a completion date of September 30, 2021. This contract was not set aside for a specific business type. The University of Oklahoma, as the prime contractor, will supply routine...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 19 to the University of Oklahoma (OU) for the provision of radiopharmaceuticals. The firm fixed price contract has a potential value of $348,137.57 and a completion date of September 30, 2022. OU, a U.S. state government educational institution, is providing routine radiopharmaceutical products to VA medical centers in Oklahoma under this contract. This...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA - VHA) awarded a $368,583.22 delivery order contract to the University Of Oklahoma Univ Of Oklahoma Health Sciences Center Division, doing business as The Board Of Regents Of The University Of Oklahoma Health Services Center, for radiopharmaceuticals. The prime contractor, which is a subsidiary of the University Of Oklahoma doing business as University Of Oklahoma Office Of Research...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 (VISN 19) to the University of Oklahoma (OU) for radiopharmaceutical service and ophthalmology services. The contract has a ceiling value of $144,000.00 and runs from October 1, 2016 to September 30, 2018. The contract was awarded as a firm fixed price contract with no set-aside designation. OU, through its University of Oklahoma Health Sciences Center division, has provided...
This is a federal contract award from the Department of Veterans Affairs' Veterans Health Administration (VHA) to the University of Oklahoma (OU) to provide radiopharmaceutical products, animal housing, and ophthalmology services to VA medical centers in Oklahoma. The contract has a potential value of $281,961.17 and was awarded on October 2, 2017 as a delivery order with a firm fixed price pricing type. The contract is not set aside for any small business category. OU, through its University of...

This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19, a civilian federal agency, to the University of Oklahoma Health Sciences Center for the delivery of radiopharmaceuticals. The contract has a ceiling value of $272,206.75 and a performance period through June 30, 2026. There is no set-aside designation indicated for this award. The University of Oklahoma Health Sciences Center is the prime contractor, and the award is associated with an Indefinite Delivery/Indefinite Quantity (IDIQ) contract the university holds with the National Cancer Institute to support preclinical drug development research for cancer prevention.

Generated 10/2/25, 11:03 AM